

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | aggressive behavior (GO:0002118) | 6.05245925 |
| 2 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.85128277 |
| 3 | DNA deamination (GO:0045006) | 4.64203070 |
| 4 | regulation of female receptivity (GO:0045924) | 4.44594163 |
| 5 | purine deoxyribonucleotide catabolic process (GO:0009155) | 4.39421508 |
| 6 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 4.33743885 |
| 7 | deoxyribonucleotide catabolic process (GO:0009264) | 4.19844177 |
| 8 | female mating behavior (GO:0060180) | 4.19435433 |
| 9 | definitive hemopoiesis (GO:0060216) | 4.14836659 |
| 10 | deoxyribose phosphate catabolic process (GO:0046386) | 3.99876571 |
| 11 | positive regulation of prostaglandin secretion (GO:0032308) | 3.91756643 |
| 12 | respiratory chain complex IV assembly (GO:0008535) | 3.90044760 |
| 13 | regulation of transmission of nerve impulse (GO:0051969) | 3.84967497 |
| 14 | hyperosmotic salinity response (GO:0042538) | 3.83284246 |
| 15 | rRNA catabolic process (GO:0016075) | 3.70883406 |
| 16 | cytochrome complex assembly (GO:0017004) | 3.66555397 |
| 17 | purine deoxyribonucleotide metabolic process (GO:0009151) | 3.60500827 |
| 18 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.54037769 |
| 19 | mature B cell differentiation involved in immune response (GO:0002313) | 3.51383512 |
| 20 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.49003723 |
| 21 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.49003723 |
| 22 | protein complex biogenesis (GO:0070271) | 3.45083592 |
| 23 | purine nucleotide salvage (GO:0032261) | 3.42684778 |
| 24 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 3.36577269 |
| 25 | daunorubicin metabolic process (GO:0044597) | 3.32790670 |
| 26 | polyketide metabolic process (GO:0030638) | 3.32790670 |
| 27 | doxorubicin metabolic process (GO:0044598) | 3.32790670 |
| 28 | regulation of skeletal muscle contraction (GO:0014819) | 3.31578400 |
| 29 | endothelium development (GO:0003158) | 3.27450631 |
| 30 | maternal behavior (GO:0042711) | 3.25290231 |
| 31 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 3.24889130 |
| 32 | negative regulation of macrophage differentiation (GO:0045650) | 3.23948504 |
| 33 | branched-chain amino acid catabolic process (GO:0009083) | 3.19067236 |
| 34 | purine-containing compound salvage (GO:0043101) | 3.16183254 |
| 35 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 3.12810739 |
| 36 | parental behavior (GO:0060746) | 3.10179404 |
| 37 | grooming behavior (GO:0007625) | 3.09234852 |
| 38 | response to interferon-beta (GO:0035456) | 3.08197893 |
| 39 | Peyers patch development (GO:0048541) | 3.06161979 |
| 40 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.06161979 |
| 41 | regulation of mitochondrial translation (GO:0070129) | 3.05529464 |
| 42 | negative regulation of B cell apoptotic process (GO:0002903) | 3.03102330 |
| 43 | regulation of prostaglandin secretion (GO:0032306) | 3.01772106 |
| 44 | deoxyribose phosphate metabolic process (GO:0019692) | 2.98207149 |
| 45 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.95773544 |
| 46 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.94575125 |
| 47 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.93640705 |
| 48 | base-excision repair, AP site formation (GO:0006285) | 2.87766057 |
| 49 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.86443298 |
| 50 | seminiferous tubule development (GO:0072520) | 2.85808672 |
| 51 | autophagic vacuole fusion (GO:0000046) | 2.85361912 |
| 52 | DNA dealkylation (GO:0035510) | 2.84321073 |
| 53 | regulation of RIG-I signaling pathway (GO:0039535) | 2.83317255 |
| 54 | monoamine transport (GO:0015844) | 2.83024134 |
| 55 | pseudouridine synthesis (GO:0001522) | 2.82317112 |
| 56 | branched-chain amino acid metabolic process (GO:0009081) | 2.82073096 |
| 57 | positive regulation of antigen processing and presentation (GO:0002579) | 2.81580243 |
| 58 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.79888877 |
| 59 | regulation of B cell apoptotic process (GO:0002902) | 2.77998437 |
| 60 | DNA integration (GO:0015074) | 2.77077706 |
| 61 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.75619075 |
| 62 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.75619075 |
| 63 | NADH dehydrogenase complex assembly (GO:0010257) | 2.75619075 |
| 64 | positive regulation of glycolytic process (GO:0045821) | 2.75058762 |
| 65 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.71969671 |
| 66 | mannosylation (GO:0097502) | 2.71370294 |
| 67 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.69721283 |
| 68 | positive regulation of amino acid transport (GO:0051957) | 2.69171206 |
| 69 | deoxyribonucleotide metabolic process (GO:0009262) | 2.66736041 |
| 70 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.62539536 |
| 71 | cellular response to exogenous dsRNA (GO:0071360) | 2.61526628 |
| 72 | positive regulation of organic acid transport (GO:0032892) | 2.61099008 |
| 73 | positive regulation of icosanoid secretion (GO:0032305) | 2.60224570 |
| 74 | ribosomal small subunit assembly (GO:0000028) | 2.60063240 |
| 75 | ATP synthesis coupled proton transport (GO:0015986) | 2.59847953 |
| 76 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.59847953 |
| 77 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.59615057 |
| 78 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.59240976 |
| 79 | response to testosterone (GO:0033574) | 2.58727763 |
| 80 | iron-sulfur cluster assembly (GO:0016226) | 2.58258189 |
| 81 | metallo-sulfur cluster assembly (GO:0031163) | 2.58258189 |
| 82 | positive regulation of fatty acid transport (GO:2000193) | 2.55510563 |
| 83 | response to pheromone (GO:0019236) | 2.55449711 |
| 84 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.54387923 |
| 85 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.54387923 |
| 86 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.54115246 |
| 87 | negative regulation of telomere maintenance (GO:0032205) | 2.53939740 |
| 88 | positive regulation of granulocyte differentiation (GO:0030854) | 2.53050570 |
| 89 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.51514364 |
| 90 | positive regulation of protein sumoylation (GO:0033235) | 2.51312886 |
| 91 | rRNA modification (GO:0000154) | 2.50104006 |
| 92 | cytidine metabolic process (GO:0046087) | 2.49903809 |
| 93 | cytidine catabolic process (GO:0006216) | 2.49903809 |
| 94 | cytidine deamination (GO:0009972) | 2.49903809 |
| 95 | positive regulation of B cell differentiation (GO:0045579) | 2.49786804 |
| 96 | regulation of antigen processing and presentation (GO:0002577) | 2.49511650 |
| 97 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.48893894 |
| 98 | positive regulation of TOR signaling (GO:0032008) | 2.47549090 |
| 99 | negative regulation of neurological system process (GO:0031645) | 2.46755376 |
| 100 | piRNA metabolic process (GO:0034587) | 2.45122653 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.28867500 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.39015929 |
| 3 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.71738079 |
| 4 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.26947445 |
| 5 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.09813285 |
| 6 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.01295924 |
| 7 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.76597676 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.67539889 |
| 9 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.63852654 |
| 10 | GATA1_22025678_ChIP-Seq_K562_Human | 2.59389058 |
| 11 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.58873619 |
| 12 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.54673294 |
| 13 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.48441300 |
| 14 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.38750396 |
| 15 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.33268204 |
| 16 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.32345131 |
| 17 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.29449209 |
| 18 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.24988537 |
| 19 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.19269776 |
| 20 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.14317303 |
| 21 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.12762816 |
| 22 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.10388794 |
| 23 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.99982237 |
| 24 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85028875 |
| 25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82108243 |
| 26 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.78485258 |
| 27 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.77019723 |
| 28 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.74544785 |
| 29 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.72769587 |
| 30 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.72478372 |
| 31 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.71386102 |
| 32 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.65365313 |
| 33 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.62963399 |
| 34 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.61345315 |
| 35 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.60494975 |
| 36 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.60054057 |
| 37 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.54723344 |
| 38 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.51320108 |
| 39 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.49586426 |
| 40 | VDR_22108803_ChIP-Seq_LS180_Human | 1.46680579 |
| 41 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.44143730 |
| 42 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36813114 |
| 43 | P300_27268052_Chip-Seq_Bcells_Human | 1.34042126 |
| 44 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.31965362 |
| 45 | AR_20517297_ChIP-Seq_VCAP_Human | 1.30967550 |
| 46 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.30340613 |
| 47 | MYB_26560356_Chip-Seq_TH2_Human | 1.28640785 |
| 48 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.27405448 |
| 49 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.25138994 |
| 50 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.24835976 |
| 51 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.23535792 |
| 52 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.22765491 |
| 53 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.22333730 |
| 54 | GATA3_26560356_Chip-Seq_TH2_Human | 1.22126414 |
| 55 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.21061266 |
| 56 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.20926685 |
| 57 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.19498230 |
| 58 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18403196 |
| 59 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.15578280 |
| 60 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.15048866 |
| 61 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.14561851 |
| 62 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.13602670 |
| 63 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.13085168 |
| 64 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.11902934 |
| 65 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.11862653 |
| 66 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11606683 |
| 67 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.11392299 |
| 68 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11229159 |
| 69 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.10743847 |
| 70 | ERA_21632823_ChIP-Seq_H3396_Human | 1.10690574 |
| 71 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.09188641 |
| 72 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.08853945 |
| 73 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.08853945 |
| 74 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.08781898 |
| 75 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.08304709 |
| 76 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.07701692 |
| 77 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.06262986 |
| 78 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.05022760 |
| 79 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.02759022 |
| 80 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.02423613 |
| 81 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.02397334 |
| 82 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.01777878 |
| 83 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.00934651 |
| 84 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.00217381 |
| 85 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.99790872 |
| 86 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.99165803 |
| 87 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.98803706 |
| 88 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.98237623 |
| 89 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.98030021 |
| 90 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.97653656 |
| 91 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.97225603 |
| 92 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.96263459 |
| 93 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.93949846 |
| 94 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.91644787 |
| 95 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.90696994 |
| 96 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.90642900 |
| 97 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.90131858 |
| 98 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.89796556 |
| 99 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.87142432 |
| 100 | NCOR_22424771_ChIP-Seq_293T_Human | 0.86818962 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003806_abnormal_nucleotide_metabolis | 3.89644093 |
| 2 | MP0005645_abnormal_hypothalamus_physiol | 3.74909612 |
| 3 | MP0009278_abnormal_bone_marrow | 3.20336862 |
| 4 | MP0005646_abnormal_pituitary_gland | 3.16481125 |
| 5 | MP0000372_irregular_coat_pigmentation | 2.71040358 |
| 6 | MP0005397_hematopoietic_system_phenotyp | 2.70337887 |
| 7 | MP0001545_abnormal_hematopoietic_system | 2.70337887 |
| 8 | MP0005075_abnormal_melanosome_morpholog | 2.56800401 |
| 9 | MP0001835_abnormal_antigen_presentation | 2.25426693 |
| 10 | MP0003195_calcinosis | 2.24839772 |
| 11 | MP0000569_abnormal_digit_pigmentation | 2.13177581 |
| 12 | MP0000465_gastrointestinal_hemorrhage | 2.06882799 |
| 13 | MP0005464_abnormal_platelet_physiology | 1.93175048 |
| 14 | MP0006036_abnormal_mitochondrial_physio | 1.91232070 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 1.88316576 |
| 16 | MP0000516_abnormal_urinary_system | 1.81587263 |
| 17 | MP0005367_renal/urinary_system_phenotyp | 1.81587263 |
| 18 | MP0008877_abnormal_DNA_methylation | 1.72381087 |
| 19 | MP0005671_abnormal_response_to | 1.68567115 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 1.64729865 |
| 21 | MP0003950_abnormal_plasma_membrane | 1.64658780 |
| 22 | MP0003787_abnormal_imprinting | 1.59477793 |
| 23 | MP0001968_abnormal_touch/_nociception | 1.59322474 |
| 24 | MP0008875_abnormal_xenobiotic_pharmacok | 1.58885683 |
| 25 | MP0003763_abnormal_thymus_physiology | 1.57858544 |
| 26 | MP0003866_abnormal_defecation | 1.55806107 |
| 27 | MP0004147_increased_porphyrin_level | 1.54022552 |
| 28 | MP0002837_dystrophic_cardiac_calcinosis | 1.53097905 |
| 29 | MP0010386_abnormal_urinary_bladder | 1.52319070 |
| 30 | MP0003718_maternal_effect | 1.51358931 |
| 31 | MP0002102_abnormal_ear_morphology | 1.51203161 |
| 32 | MP0009697_abnormal_copulation | 1.49801996 |
| 33 | MP0005174_abnormal_tail_pigmentation | 1.49725117 |
| 34 | MP0001905_abnormal_dopamine_level | 1.48095214 |
| 35 | MP0009840_abnormal_foam_cell | 1.46461707 |
| 36 | MP0005084_abnormal_gallbladder_morpholo | 1.46365551 |
| 37 | MP0008872_abnormal_physiological_respon | 1.44869420 |
| 38 | MP0003303_peritoneal_inflammation | 1.42273800 |
| 39 | MP0005000_abnormal_immune_tolerance | 1.37820599 |
| 40 | MP0002876_abnormal_thyroid_physiology | 1.37217781 |
| 41 | MP0006292_abnormal_olfactory_placode | 1.36031757 |
| 42 | MP0003724_increased_susceptibility_to | 1.31567828 |
| 43 | MP0002163_abnormal_gland_morphology | 1.29612469 |
| 44 | MP0001790_abnormal_immune_system | 1.29344040 |
| 45 | MP0005387_immune_system_phenotype | 1.29344040 |
| 46 | MP0002132_abnormal_respiratory_system | 1.27317479 |
| 47 | MP0000685_abnormal_immune_system | 1.22296955 |
| 48 | MP0002234_abnormal_pharynx_morphology | 1.21328711 |
| 49 | MP0002138_abnormal_hepatobiliary_system | 1.21167796 |
| 50 | MP0009333_abnormal_splenocyte_physiolog | 1.20115223 |
| 51 | MP0001764_abnormal_homeostasis | 1.19778915 |
| 52 | MP0001986_abnormal_taste_sensitivity | 1.19305567 |
| 53 | MP0001800_abnormal_humoral_immune | 1.18629148 |
| 54 | MP0002653_abnormal_ependyma_morphology | 1.17988798 |
| 55 | MP0009785_altered_susceptibility_to | 1.17478170 |
| 56 | MP0005332_abnormal_amino_acid | 1.16172609 |
| 57 | MP0003186_abnormal_redox_activity | 1.16098121 |
| 58 | MP0002693_abnormal_pancreas_physiology | 1.13514972 |
| 59 | MP0009643_abnormal_urine_homeostasis | 1.11005185 |
| 60 | MP0002723_abnormal_immune_serum | 1.10405184 |
| 61 | MP0002420_abnormal_adaptive_immunity | 1.10211373 |
| 62 | MP0001873_stomach_inflammation | 1.10146931 |
| 63 | MP0005025_abnormal_response_to | 1.10060331 |
| 64 | MP0000013_abnormal_adipose_tissue | 1.09544399 |
| 65 | MP0005379_endocrine/exocrine_gland_phen | 1.09497855 |
| 66 | MP0001819_abnormal_immune_cell | 1.07798813 |
| 67 | MP0000015_abnormal_ear_pigmentation | 1.07466020 |
| 68 | MP0000689_abnormal_spleen_morphology | 1.06348634 |
| 69 | MP0002452_abnormal_antigen_presenting | 1.05884006 |
| 70 | MP0005636_abnormal_mineral_homeostasis | 1.04772292 |
| 71 | MP0003786_premature_aging | 1.04434930 |
| 72 | MP0008058_abnormal_DNA_repair | 1.04384171 |
| 73 | MP0006072_abnormal_retinal_apoptosis | 1.03110436 |
| 74 | MP0002398_abnormal_bone_marrow | 1.02382819 |
| 75 | MP0004043_abnormal_pH_regulation | 0.99845750 |
| 76 | MP0000716_abnormal_immune_system | 0.99592674 |
| 77 | MP0003075_altered_response_to | 0.98973781 |
| 78 | MP0001664_abnormal_digestion | 0.98015744 |
| 79 | MP0005410_abnormal_fertilization | 0.94941566 |
| 80 | MP0001853_heart_inflammation | 0.92929047 |
| 81 | MP0001881_abnormal_mammary_gland | 0.92414108 |
| 82 | MP0006035_abnormal_mitochondrial_morpho | 0.90903939 |
| 83 | MP0002396_abnormal_hematopoietic_system | 0.89340130 |
| 84 | MP0002095_abnormal_skin_pigmentation | 0.88633062 |
| 85 | MP0005360_urolithiasis | 0.88510607 |
| 86 | MP0002429_abnormal_blood_cell | 0.86700509 |
| 87 | MP0000230_abnormal_systemic_arterial | 0.86409946 |
| 88 | MP0006276_abnormal_autonomic_nervous | 0.85426583 |
| 89 | MP0002722_abnormal_immune_system | 0.84307114 |
| 90 | MP0001845_abnormal_inflammatory_respons | 0.83182468 |
| 91 | MP0002638_abnormal_pupillary_reflex | 0.82714196 |
| 92 | MP0004885_abnormal_endolymph | 0.82475096 |
| 93 | MP0008469_abnormal_protein_level | 0.81679218 |
| 94 | MP0003172_abnormal_lysosome_physiology | 0.80283254 |
| 95 | MP0005165_increased_susceptibility_to | 0.79251163 |
| 96 | MP0002405_respiratory_system_inflammati | 0.78547555 |
| 97 | MP0005266_abnormal_metabolism | 0.77206499 |
| 98 | MP0005220_abnormal_exocrine_pancreas | 0.75114387 |
| 99 | MP0002822_catalepsy | 0.75013793 |
| 100 | MP0004145_abnormal_muscle_electrophysio | 0.73386752 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Stomatitis (HP:0010280) | 4.28678223 |
| 2 | Microvesicular hepatic steatosis (HP:0001414) | 3.99414029 |
| 3 | Acute necrotizing encephalopathy (HP:0006965) | 3.96660948 |
| 4 | Mitochondrial inheritance (HP:0001427) | 3.94468983 |
| 5 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.93837162 |
| 6 | Acute encephalopathy (HP:0006846) | 3.65509076 |
| 7 | Progressive macrocephaly (HP:0004481) | 3.48473568 |
| 8 | Type 2 muscle fiber atrophy (HP:0003554) | 3.48123129 |
| 9 | Aplastic anemia (HP:0001915) | 3.43373035 |
| 10 | Increased CSF lactate (HP:0002490) | 3.40827206 |
| 11 | Hepatocellular necrosis (HP:0001404) | 3.34774604 |
| 12 | 3-Methylglutaconic aciduria (HP:0003535) | 3.34187689 |
| 13 | Dicarboxylic aciduria (HP:0003215) | 3.33122009 |
| 14 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.33122009 |
| 15 | Lipid accumulation in hepatocytes (HP:0006561) | 3.26641903 |
| 16 | Hepatic necrosis (HP:0002605) | 3.23497394 |
| 17 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.21408655 |
| 18 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.21408655 |
| 19 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.06954634 |
| 20 | Cerebral edema (HP:0002181) | 3.01386369 |
| 21 | Muscle fiber atrophy (HP:0100295) | 2.97425169 |
| 22 | Ketoacidosis (HP:0001993) | 2.95292850 |
| 23 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.94720450 |
| 24 | Increased muscle lipid content (HP:0009058) | 2.94348883 |
| 25 | Increased hepatocellular lipid droplets (HP:0006565) | 2.84914774 |
| 26 | Increased intramyocellular lipid droplets (HP:0012240) | 2.80140804 |
| 27 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.72435183 |
| 28 | Severe combined immunodeficiency (HP:0004430) | 2.71570958 |
| 29 | Type I transferrin isoform profile (HP:0003642) | 2.69144271 |
| 30 | Hyperglycinemia (HP:0002154) | 2.65285770 |
| 31 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.64617326 |
| 32 | Abnormal pupillary function (HP:0007686) | 2.61919801 |
| 33 | Ketosis (HP:0001946) | 2.60457134 |
| 34 | Hyperthyroidism (HP:0000836) | 2.58303689 |
| 35 | Agammaglobulinemia (HP:0004432) | 2.56743283 |
| 36 | Lactic acidosis (HP:0003128) | 2.56392567 |
| 37 | Thyroiditis (HP:0100646) | 2.53865910 |
| 38 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.49217715 |
| 39 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.48996053 |
| 40 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.48996053 |
| 41 | Abnormal protein glycosylation (HP:0012346) | 2.48996053 |
| 42 | Abnormal glycosylation (HP:0012345) | 2.48996053 |
| 43 | Congenital stationary night blindness (HP:0007642) | 2.46042380 |
| 44 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.39286860 |
| 45 | Hypoglycemic seizures (HP:0002173) | 2.38258934 |
| 46 | Lethargy (HP:0001254) | 2.37537308 |
| 47 | Optic disc pallor (HP:0000543) | 2.37171668 |
| 48 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.36167398 |
| 49 | Abnormality of B cell number (HP:0010975) | 2.28647659 |
| 50 | Abnormality of the renal cortex (HP:0011035) | 2.26695517 |
| 51 | Attenuation of retinal blood vessels (HP:0007843) | 2.26237850 |
| 52 | Exercise intolerance (HP:0003546) | 2.21687488 |
| 53 | Abnormality of iron homeostasis (HP:0011031) | 2.19177869 |
| 54 | Renal Fanconi syndrome (HP:0001994) | 2.16949095 |
| 55 | Exertional dyspnea (HP:0002875) | 2.13349598 |
| 56 | Molar tooth sign on MRI (HP:0002419) | 2.13090465 |
| 57 | Abnormality of midbrain morphology (HP:0002418) | 2.13090465 |
| 58 | Brushfield spots (HP:0001088) | 2.10798293 |
| 59 | Cerebral palsy (HP:0100021) | 2.10717106 |
| 60 | Increased serum ferritin (HP:0003281) | 2.08808061 |
| 61 | Petechiae (HP:0000967) | 2.08223500 |
| 62 | Hypoproteinemia (HP:0003075) | 2.08162907 |
| 63 | Thrombocytosis (HP:0001894) | 2.06268050 |
| 64 | Methylmalonic aciduria (HP:0012120) | 2.04859786 |
| 65 | Respiratory failure (HP:0002878) | 2.04168599 |
| 66 | Calf muscle hypertrophy (HP:0008981) | 2.03890007 |
| 67 | Exercise-induced myalgia (HP:0003738) | 2.02705436 |
| 68 | Decreased central vision (HP:0007663) | 2.02106778 |
| 69 | Opisthotonus (HP:0002179) | 2.00628006 |
| 70 | Increased serum lactate (HP:0002151) | 2.00088734 |
| 71 | Chronic obstructive pulmonary disease (HP:0006510) | 1.98626532 |
| 72 | Obstructive lung disease (HP:0006536) | 1.98626532 |
| 73 | Autoimmune hemolytic anemia (HP:0001890) | 1.97528180 |
| 74 | Abnormality of the prostate (HP:0008775) | 1.96792360 |
| 75 | Renal cortical cysts (HP:0000803) | 1.91765076 |
| 76 | Severe visual impairment (HP:0001141) | 1.91553265 |
| 77 | Pancreatic cysts (HP:0001737) | 1.90886698 |
| 78 | Abolished electroretinogram (ERG) (HP:0000550) | 1.88963157 |
| 79 | Abnormal number of erythroid precursors (HP:0012131) | 1.88427732 |
| 80 | Bile duct proliferation (HP:0001408) | 1.88154308 |
| 81 | Abnormal biliary tract physiology (HP:0012439) | 1.88154308 |
| 82 | Episodic fever (HP:0001954) | 1.87781497 |
| 83 | Palpitations (HP:0001962) | 1.87123012 |
| 84 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.86671641 |
| 85 | Leukocytosis (HP:0001974) | 1.86137674 |
| 86 | Anhidrosis (HP:0000970) | 1.84811813 |
| 87 | Hyperglycinuria (HP:0003108) | 1.82629873 |
| 88 | Recurrent fungal infections (HP:0002841) | 1.82240994 |
| 89 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.81676033 |
| 90 | Combined immunodeficiency (HP:0005387) | 1.81544095 |
| 91 | Abnormality of DNA repair (HP:0003254) | 1.80786234 |
| 92 | B lymphocytopenia (HP:0010976) | 1.80190488 |
| 93 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.78699490 |
| 94 | Fatigable weakness (HP:0003473) | 1.78416161 |
| 95 | Abnormality of the neuromuscular junction (HP:0003398) | 1.78416161 |
| 96 | Pancytopenia (HP:0001876) | 1.76143224 |
| 97 | Abnormality of dental color (HP:0011073) | 1.76109539 |
| 98 | Hypertensive crisis (HP:0100735) | 1.74955113 |
| 99 | Progressive microcephaly (HP:0000253) | 1.74675567 |
| 100 | Asymmetric septal hypertrophy (HP:0001670) | 1.74606578 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.12578361 |
| 2 | MUSK | 3.26401545 |
| 3 | VRK2 | 3.10091251 |
| 4 | MAP4K2 | 2.94861802 |
| 5 | KDR | 2.88877561 |
| 6 | TAOK3 | 2.68538542 |
| 7 | SCYL2 | 2.58636798 |
| 8 | MAP3K11 | 2.54527797 |
| 9 | TESK2 | 2.39483588 |
| 10 | MAPKAPK3 | 2.30348616 |
| 11 | FES | 2.28453031 |
| 12 | PIK3CG | 2.20766610 |
| 13 | FRK | 2.19164555 |
| 14 | KIT | 2.18098430 |
| 15 | TXK | 2.09716084 |
| 16 | NME2 | 2.08806173 |
| 17 | NUAK1 | 2.04449141 |
| 18 | PBK | 1.96624641 |
| 19 | DAPK1 | 1.87806279 |
| 20 | PINK1 | 1.73853997 |
| 21 | DAPK2 | 1.71100784 |
| 22 | MAP4K1 | 1.69491868 |
| 23 | MATK | 1.66177294 |
| 24 | EIF2AK1 | 1.37465259 |
| 25 | MAPKAPK5 | 1.29075764 |
| 26 | TEC | 1.25706999 |
| 27 | IKBKB | 1.24972565 |
| 28 | CDK19 | 1.23678151 |
| 29 | PASK | 1.18892883 |
| 30 | NME1 | 1.18492800 |
| 31 | ADRBK2 | 1.16829171 |
| 32 | FLT3 | 1.11897802 |
| 33 | VRK1 | 1.07199227 |
| 34 | BMPR2 | 1.07137592 |
| 35 | SYK | 1.06691819 |
| 36 | TIE1 | 1.05260013 |
| 37 | TESK1 | 1.02992653 |
| 38 | TBK1 | 1.01357242 |
| 39 | JAK3 | 0.98265635 |
| 40 | GRK1 | 0.97024833 |
| 41 | RPS6KB2 | 0.97017895 |
| 42 | PIM2 | 0.93945820 |
| 43 | TAOK2 | 0.92444488 |
| 44 | PTK2B | 0.92277942 |
| 45 | CCNB1 | 0.91640756 |
| 46 | INSRR | 0.89056435 |
| 47 | OXSR1 | 0.86322703 |
| 48 | EIF2AK3 | 0.84071788 |
| 49 | MAP3K12 | 0.82339854 |
| 50 | GRK6 | 0.82327481 |
| 51 | PRKCQ | 0.81605369 |
| 52 | ITK | 0.79022324 |
| 53 | TNK2 | 0.77375662 |
| 54 | PHKG1 | 0.75577202 |
| 55 | PHKG2 | 0.75577202 |
| 56 | ABL2 | 0.72641030 |
| 57 | TAOK1 | 0.71985043 |
| 58 | BTK | 0.69975489 |
| 59 | CSNK1G3 | 0.68698262 |
| 60 | LCK | 0.67853769 |
| 61 | CDK8 | 0.66100716 |
| 62 | LYN | 0.65371841 |
| 63 | IKBKE | 0.63076406 |
| 64 | MST4 | 0.60565069 |
| 65 | CAMKK2 | 0.59147574 |
| 66 | CSF1R | 0.58714896 |
| 67 | ADRBK1 | 0.55903527 |
| 68 | CSNK1G2 | 0.53660263 |
| 69 | ATR | 0.52453837 |
| 70 | GRK5 | 0.52405922 |
| 71 | BMPR1B | 0.51756603 |
| 72 | MAPK11 | 0.51509782 |
| 73 | ZAK | 0.51452763 |
| 74 | DAPK3 | 0.48632183 |
| 75 | IGF1R | 0.46932636 |
| 76 | WNK4 | 0.46414937 |
| 77 | LIMK1 | 0.45031744 |
| 78 | TAF1 | 0.44942386 |
| 79 | STK39 | 0.43912045 |
| 80 | MAP3K3 | 0.43229502 |
| 81 | RPS6KA5 | 0.41072816 |
| 82 | MAP2K6 | 0.40725020 |
| 83 | CSNK1G1 | 0.40500693 |
| 84 | OBSCN | 0.39984268 |
| 85 | PRKCA | 0.39947352 |
| 86 | ERN1 | 0.36702725 |
| 87 | GRK7 | 0.36635916 |
| 88 | MAP2K3 | 0.36431760 |
| 89 | FER | 0.35570717 |
| 90 | MAP3K1 | 0.35251897 |
| 91 | ABL1 | 0.35129920 |
| 92 | CDK9 | 0.35128233 |
| 93 | CSK | 0.33080834 |
| 94 | PRKG2 | 0.33001540 |
| 95 | PIK3CA | 0.32599214 |
| 96 | PRKACB | 0.32511841 |
| 97 | HCK | 0.32492031 |
| 98 | WNK3 | 0.31714537 |
| 99 | RPS6KA6 | 0.31067498 |
| 100 | EIF2AK2 | 0.30656640 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.87358966 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 2.81343266 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.71442005 |
| 4 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.63823938 |
| 5 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.45692347 |
| 6 | Parkinsons disease_Homo sapiens_hsa05012 | 2.35215148 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.31051630 |
| 8 | Ribosome_Homo sapiens_hsa03010 | 2.30189470 |
| 9 | Peroxisome_Homo sapiens_hsa04146 | 2.24683521 |
| 10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.23748362 |
| 11 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.23448742 |
| 12 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.18716566 |
| 13 | Allograft rejection_Homo sapiens_hsa05330 | 2.18355274 |
| 14 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.11878001 |
| 15 | Asthma_Homo sapiens_hsa05310 | 2.08228929 |
| 16 | Base excision repair_Homo sapiens_hsa03410 | 1.94114572 |
| 17 | RNA polymerase_Homo sapiens_hsa03020 | 1.80218386 |
| 18 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.79630846 |
| 19 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.78213489 |
| 20 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.73642685 |
| 21 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.60757793 |
| 22 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.58924481 |
| 23 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.53350993 |
| 24 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.49275747 |
| 25 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.48806508 |
| 26 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.42389692 |
| 27 | Protein export_Homo sapiens_hsa03060 | 1.42076393 |
| 28 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.37840116 |
| 29 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.37376972 |
| 30 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.37078273 |
| 31 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.36221960 |
| 32 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.32414939 |
| 33 | DNA replication_Homo sapiens_hsa03030 | 1.29267802 |
| 34 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.28229864 |
| 35 | Alzheimers disease_Homo sapiens_hsa05010 | 1.25452509 |
| 36 | Phototransduction_Homo sapiens_hsa04744 | 1.22643102 |
| 37 | Huntingtons disease_Homo sapiens_hsa05016 | 1.18222995 |
| 38 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.14323253 |
| 39 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.12877374 |
| 40 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.11521120 |
| 41 | Purine metabolism_Homo sapiens_hsa00230 | 1.11144016 |
| 42 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.10282385 |
| 43 | RNA degradation_Homo sapiens_hsa03018 | 1.10181842 |
| 44 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.06766282 |
| 45 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.05402985 |
| 46 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.05259497 |
| 47 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.04453781 |
| 48 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.04332923 |
| 49 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.01522613 |
| 50 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.99711346 |
| 51 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.99561205 |
| 52 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.98752593 |
| 53 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.98180356 |
| 54 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.97632201 |
| 55 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.96774722 |
| 56 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.95876828 |
| 57 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.95001901 |
| 58 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.94124620 |
| 59 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.92687269 |
| 60 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.89408194 |
| 61 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.89131428 |
| 62 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.87002189 |
| 63 | Mismatch repair_Homo sapiens_hsa03430 | 0.85784094 |
| 64 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.85178279 |
| 65 | Homologous recombination_Homo sapiens_hsa03440 | 0.81543209 |
| 66 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.80789425 |
| 67 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.80281974 |
| 68 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.77471270 |
| 69 | Metabolic pathways_Homo sapiens_hsa01100 | 0.75230572 |
| 70 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.73287656 |
| 71 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.70205856 |
| 72 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.68043525 |
| 73 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.67879786 |
| 74 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.67718969 |
| 75 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.67229665 |
| 76 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.67133556 |
| 77 | Viral myocarditis_Homo sapiens_hsa05416 | 0.63493551 |
| 78 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.63275916 |
| 79 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.62596124 |
| 80 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.61519414 |
| 81 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.56826865 |
| 82 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.54554524 |
| 83 | Sulfur relay system_Homo sapiens_hsa04122 | 0.50954567 |
| 84 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.50776829 |
| 85 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.50397005 |
| 86 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.48387593 |
| 87 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.48192517 |
| 88 | Retinol metabolism_Homo sapiens_hsa00830 | 0.48186651 |
| 89 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.48015962 |
| 90 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.44618965 |
| 91 | Platelet activation_Homo sapiens_hsa04611 | 0.43856378 |
| 92 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.42890493 |
| 93 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.40643178 |
| 94 | Basal transcription factors_Homo sapiens_hsa03022 | 0.34552500 |
| 95 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.33908156 |
| 96 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.33413305 |
| 97 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.33263662 |
| 98 | Carbon metabolism_Homo sapiens_hsa01200 | 0.31946002 |
| 99 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.30511010 |
| 100 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.29982055 |

